Glenmark Pharmaceuticals Shares Surge 3.28% Amid Market Decline
Glenmark Pharmaceuticals Ltd spurts 3.28%
Business Standard
Image: Business Standard
Glenmark Pharmaceuticals Ltd shares rose by 3.28% to ₹2313.4 on the National Stock Exchange (NSE) amid a broader market downturn. Over the past year, the stock has appreciated 62.81%, significantly outperforming the NIFTY index, which has seen a slight decline of 0.21%.
- 01Glenmark Pharmaceuticals shares increased by 3.28% today.
- 02The stock has surged 62.81% over the past year.
- 03NIFTY index is down 0.21% during the same period.
- 04Glenmark's stock volume today was 11.71 lakh shares.
- 05The stock's price-to-earnings ratio is 42.64.
Advertisement
In-Article Ad
Glenmark Pharmaceuticals Ltd's shares rose 3.28% to ₹2313.4 as of 12:49 IST on the National Stock Exchange (NSE), marking the third consecutive day of gains for the company. Over the past year, Glenmark's stock has appreciated 62.81%, significantly outperforming the NIFTY index, which has dropped 0.21%, and the Nifty Pharma index, down 4.48%. In the last month alone, Glenmark's stock has risen by 10.39%, while the Nifty Pharma index has only seen a 3.23% increase. Today's trading volume for Glenmark stood at 11.71 lakh shares, exceeding the monthly average of 6.02 lakh shares. The stock's price-to-earnings ratio is currently 42.64, based on trailing twelve-month earnings ending December 25.
Advertisement
In-Article Ad
The rise in Glenmark's stock price may positively affect investor sentiment and could lead to increased investment in the pharmaceutical sector.
Advertisement
In-Article Ad
Reader Poll
Do you think Glenmark Pharmaceuticals will continue to rise in the next quarter?
Connecting to poll...
Read the original article
Visit the source for the complete story.